Allergy Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	10.08	12.79	12.92	14.85	20.52	40.27
Cash & Short-Term Investments	10.08	12.79	12.92	14.85	20.52	40.27
Cash Growth	-53.48%	-0.97%	-13.00%	-27.64%	-49.06%	8.96%
Accounts Receivable	10.98	2.85	2.86	2.37	2.69	2.96
Other Receivables	1.4	3.19	3.35	2.69	3.21	1.66
Receivables	12.38	6.03	6.21	5.06	5.91	4.62
Inventory	13.79	13.92	12.74	11.59	11.41	10.84
Prepaid Expenses	-	1.94	1.62	2.03	4.56	1.6
Other Current Assets	-	-	-	-	-	0.53
Total Current Assets	36.25	34.68	33.48	33.53	42.39	57.86
Property, Plant & Equipment	26.39	24.26	23.75	23.24	20.19	19.72
Goodwill	3.34	3.33	3.32	3.35	3.35	3.34
Other Intangible Assets	0.86	0.93	1.37	1.79	1.69	1.41
Long-Term Deferred Tax Assets	1.39	1.51	1.58	-	-	-
Other Long-Term Assets	2.78	2.84	2.91	4.87	5.33	5.76
Total Assets	71	67.54	66.41	66.77	72.95	88.09
Accounts Payable	13.95	4.49	4.01	4.09	4.28	2.9
Accrued Expenses	-	8.1	8.65	12.49	11.34	13.55
Current Portion of Long-Term Debt	0.45	0.41	0.6	0.65	0.95	0.96
Current Portion of Leases	1.51	1.48	1.52	1.16	1.32	0.79
Current Income Taxes Payable	1.3	0.91	1.43	-	-	-
Other Current Liabilities	14.82	11.81	2.59	0.18	0.16	0.03
Total Current Liabilities	32.03	27.19	18.8	18.57	18.05	18.23
Long-Term Debt	19.71	53.04	22.5	26.44	1.5	2.45
Long-Term Leases	5.08	5.17	6.37	7.75	6.76	6.97
Pension & Post-Retirement Benefits	8.23	8.59	8.61	7.92	8.32	11.29
Long-Term Deferred Tax Liabilities	0.05	0.07	0.06	0.45	0.41	0.41
Other Long-Term Liabilities	1.66	1.68	2.71	3.58	0.14	0.21
Total Liabilities	66.76	95.74	59.05	64.7	35.18	39.55
Common Stock	6.14	4.77	4.77	0.68	0.64	0.64
Additional Paid-In Capital	208.13	154.64	154.64	119.03	112.58	112.58
Retained Earnings	-254.34	-235.23	-195.28	-161.87	-118.54	-107.4
Comprehensive Income & Other	44.32	47.63	43.23	44.23	43.09	42.72
Shareholders' Equity	4.25	-28.19	7.36	2.07	37.77	48.54
Total Liabilities & Equity	71	67.54	66.41	66.77	72.95	88.09
Total Debt	26.75	60.09	30.99	35.99	10.53	11.17
Net Cash (Debt)	-16.67	-47.3	-18.07	-21.14	9.99	29.1
Net Cash Growth	-	-	-	-	-65.69%	17.42%
Net Cash Per Share	-0.00	-0.01	-0.00	-0.03	0.02	0.04
Filing Date Shares Outstanding	6,141	4,766	4,766	679.1	644.1	641.77
Total Common Shares Outstanding	6,141	4,766	4,766	679.1	644.1	641.77
Working Capital	4.22	7.49	14.68	14.96	24.34	39.63
Book Value Per Share	0.00	-0.01	0.00	0.00	0.06	0.08
Tangible Book Value	0.05	-32.45	2.67	-3.07	32.73	43.78
Tangible Book Value Per Share	0.00	-0.01	0.00	-0.00	0.05	0.07
Land	-	3.14	3.01	3.05	3.08	3.09
Machinery	-	40.29	36.96	33.68	29.66	27.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.